A carregar...
Enhanced tumour antiangiogenic effects when combining gefitinib with the antivascular agent ZD6126
Current experimental and clinical knowledge supports the optimisation of endothelial cell targeting using a strategy combining anti-EGFR drugs with antivascular agents. The purpose of the present study was to examine the effects of the association of ZD6126, an antivascular microtubule-destabilising...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2006
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2360508/ https://ncbi.nlm.nih.gov/pubmed/16940984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603308 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|